Cellectar Biosciences Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)	4.63M	3.94M	4.39M	3.70M	4.14M	5.21M	4.50M	6.36M	6.14M	7.03M	7.74M	7.09M	7.35M	5.49M	6.21M	3.43M	2.39M	2.52M	3.16M	4.56M
Selling, General & Administrative (Quarter)	1.40M	1.88M	1.54M	2.44M	3.29M	2.60M	2.92M	2.35M	2.16M	2.38M	4.81M	4.91M	6.36M	7.83M	6.54M	2.97M	3.65M	2.33M	2.53M	2.64M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	6.03M	5.82M	5.92M	6.14M	7.44M	7.82M	7.42M	8.71M	8.29M	9.41M	12.55M	12.00M	13.70M	13.33M	12.74M	6.40M	6.04M	4.85M	5.69M	7.20M
Operating Income (Quarter)	-6.03M	-5.82M	-5.92M	-6.14M	-7.44M	-7.82M	-7.42M	-8.71M	-8.29M	-9.41M	-12.55M	-12.00M	-13.70M	-13.33M	-12.74M	-6.40M	-6.04M	-4.85M	-5.69M	-7.20M
EBIT (Quarter)	-6.03M	-5.82M	-5.92M	-6.14M	-7.44M	-7.82M	-7.42M	-8.71M	-8.29M	-9.41M	-12.55M	-12.00M	-13.70M	-13.33M	-12.74M	-6.40M	-6.04M	-4.85M	-5.69M	-7.20M
Non-operating items
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	659.00	590.00	0.01M	-0.10M	481.00	0.30M	-5.04M	1.51M	-1.88M	-8.11M	0.14M	0.32M	12.78M	-1.34M	4.40M	-0.20M	0.59M	0.41M	-0.36M	0.27M
Net income details
EBT (Quarter)	-6.44M	-6.19M	-6.15M	-6.14M	-7.44M	-8.03M	-80.35M	-8.85M	-8.57M	-9.67M	-14.23M	-12.77M	-14.43M	-14.02M	-120.23M	-6.56M	-6.62M	-5.01M	-5.85M	-9.34M
Profit After Tax (Quarter)	-6.03M	-5.82M	-5.92M	-6.24M	-5.64M	-7.51M	-12.41M	-7.19M	-10.18M	-17.52M	-7.88M	-26.64M	-0.92M	-14.66M	-2.36M	-6.60M	-5.45M	-4.44M	-5.30M	-6.93M
Income from Continuing Operations (Quarter)	-6.44M	-6.19M	-6.15M	-6.14M	-7.44M	-8.03M	-80.35M	-8.85M	-8.57M	-9.67M	-14.23M	-12.77M	-14.43M	-14.02M	-120.23M	-6.56M	-6.62M	-5.01M	-5.85M	-9.34M
Consolidated Net Income (Quarter)	-6.44M	-6.19M	-6.15M	-6.14M	-7.44M	-8.03M	-80.35M	-8.85M	-8.57M	-9.67M	-14.23M	-12.77M	-14.43M	-14.02M	-120.23M	-6.56M	-6.62M	-5.01M	-5.85M	-9.34M
Income towards Parent Company (Quarter)	-6.44M	-6.19M	-6.15M	-6.14M	-7.44M	-8.03M	-80.35M	-8.85M	-8.57M	-9.67M	-14.23M	-12.77M	-14.43M	-14.02M	-120.23M	-6.56M	-6.62M	-5.01M	-5.85M	-9.34M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-6.44M	-6.19M	-6.15M	-6.14M	-7.44M	-8.03M	-80.35M	-8.85M	-8.57M	-9.67M	-14.23M	-12.77M	-14.43M	-14.02M	-120.23M	-6.56M	-6.62M	-5.01M	-5.85M	-9.34M
Additional items
EPS (Basic) (Quarter)	-36.62	-31.03	-33.26	-30.15	-36.51	-39.43	-341.66	-23.59	-22.83	-25.65	-34.93	-13.05	-12.09	-10.69	-98.50	-4.27	-4.12	-1.58	-2.24	-3.58
EPS (Diluted) (Quarter)	-36.62	-31.03	-33.26	-30.15	-36.51	-39.43	-341.66	-23.59	-22.83	-25.65	-34.93	-13.05	-11.56	-10.57	-97.12	-4.27	-4.12	-1.58	-2.24	-3.58
Shares Outstanding (Quarter)	0.18M	0.20M	0.19M	0.20M	0.20M	0.20M	0.24M	0.38M	0.38M	0.38M	0.41M	0.98M	1.19M	1.31M	1.22M	1.54M	1.61M	3.16M	2.61M	2.61M
Shares Outstanding (Diluted) (Quarter)	0.18M	0.20M	0.19M	0.20M	0.20M	0.20M	0.24M	0.38M	0.38M	0.38M	0.41M	0.98M	1.25M	1.33M	1.24M	1.54M	1.61M	3.16M	2.61M	2.61M
Shares Outstanding (Entity) (Quarter)	0.18M	0.20M	0.20M	0.20M	0.20M	0.20M	0.24M	0.32M	0.32M	0.33M	0.41M	1.11M	1.19M	1.35M	1.22M	1.54M	1.81M	3.19M	2.61M
EBITDA (Quarter)	-6.03M	-5.82M	-5.92M	-6.14M	-7.44M	-7.82M	-7.42M	-8.71M	-8.29M	-9.41M	-12.55M	-12.00M	-13.70M	-13.33M	-12.74M	-6.40M	-6.04M	-4.85M	-5.69M	-7.20M
Interest Expenses (Quarter)	0.41M	0.37M	0.23M			0.21M	72.92M	0.15M	0.28M	0.26M	1.68M	0.77M	0.73M	0.69M	107.48M	0.16M	0.58M	0.16M	0.15M	2.14M

Research Tools

Datasets

Plans

Developers

Cellectar Biosciences CLRB Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Cellectar Biosciences CLRB Income Statement (2010-2026)

Create an account

Sign In

Reset Password